GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: Example 1 [US20090137530] | MT-1303 | MT1303
                                 Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Amiselimod (MT-1303) is claimed in patent US20090137530 (Compound 1-3 is the hydrochloride used experimentally) as a potential immunomodulatory agent [1]. It is a sphingosine-1-phosphate (SIP) receptor prodrug agonist, similar in action to the approved MS drug fingolimod, but with improved receptor subtype selectivity [3]. Selective SIP1 receptor agonists are being investigated for immunomodulatory/immunosuppresant action in MS and other autoimmune conditions [2]. | 
 | |||||||||||||||||||||||||||||||||||
| Classification  | |
| Compound class | Synthetic organic | 
| Is prodrug? | Yes | 
| Active form | amiselimod phosphate | 
| IUPAC Name  | 
| 2-amino-2-[2-[4-heptoxy-3-(trifluoromethyl)phenyl]ethyl]propane-1,3-diol | 
| International Nonproprietary Names  | |
| INN number | INN | 
| 10021 | amiselimod | 
| Synonyms  | 
| Example 1 [US20090137530] | MT-1303 | MT1303 | 
| Database Links  | |
| CAS Registry No. | 942399-20-4 (source: WHO INN record) | 
| GtoPdb PubChem SID | 318164838 | 
| PubChem CID | 16129483 | 
| Search Google for chemical match using the InChIKey | JVCPIJKPAKAIIP-UHFFFAOYSA-N | 
| Search Google for chemicals with the same backbone | JVCPIJKPAKAIIP | 
| Search PubMed clinical trials | amiselimod | 
| Search PubMed titles | amiselimod | 
| Search PubMed titles/abstracts | amiselimod | 
| UniChem Compound Search for chemical match using the InChIKey | JVCPIJKPAKAIIP-UHFFFAOYSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | JVCPIJKPAKAIIP-UHFFFAOYSA-N |